Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tomoyuki Katsuzaki"'
Autor:
Takashi Akiba, Takashi Miyazaki, Tomoyuki Katsuzaki, Fumitaka Hayase, Tomoko Momoi, Kazuya Nokura, Takei Yoshifumi, Toshimitsu Niwa, Noriyuki Tatemichi, Shigeru Miyazaki
Publikováno v:
Kidney International. 51(1):187-194
Amyloid β2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis. We have recently demonstrated by immunohistochemistry that amyloid β2-microglobulin (β2m) is modified with advanced gly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31178e0e151ae4bd02043c59ea523e64
Autor:
Takashi Morita, Yoshihei Hirasawa, Takashi Miyazaki, Shigeru Miyazaki, Noriyuki Tatemichi, Tomoyuki Katsuzaki, Yoshifumi Takei, Toshimitsu Niwa
Publikováno v:
Kidney International. 48:771-778
Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis. β 2 -Microglobulin (β 2 m) isolated from the amyloid deposits in patients with dialysis-related amyloidosis (DRA) has been demonstrated to be modified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd2ff4de7dc90221eaec03fc2f311de
https://doi.org/10.1038/ki.1995.349
https://doi.org/10.1038/ki.1995.349
Autor:
Yoshifumi Takei, Kenji Maeda, Takashi Morita, Yoshihei Hirasawa, Toshimitsu Niwa, Shigeru Miyazaki, Noriyuki Tatemichi, Takashi Miyazaki, Tomoyuki Katsuzaki
Publikováno v:
Nihon Toseki Igakkai Zasshi. 28:865-871
透析アミロイドーシス患者のアミロイド組織から抽出されたβ2-microgiobulin (β2M) はMaillard反応によりadvanced glycation end products (AGE) により修飾されていることが報告された. 我々はAGEに特異的
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9990a65c3bf2826a20165ec50d80c7f3
https://doi.org/10.4009/jsdt.28.865
https://doi.org/10.4009/jsdt.28.865
Autor:
Tomoyuki Katsuzaki, Takaharu Kondo, Makoto Tanikawa, Yuzo Sakai, Noriyuki Tatemichi, Motoji Kitagawa, Shinobu Hayakawa, Yasuyuki Nakae, Tokimune Shibata, Tetsuo Hayakawa, Hiroshi Sobajima
Publikováno v:
International journal of pancreatology. 13:97-103
Serum pancreatic stone protein (PSP) was determined in sera of pancreatic and nonpancreatic diseases using enzyme immunoassay specific to human PSP to study the diagnostic and pathophysiological significance of PSP. Serum PSP in acute pancreatitis (m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bfac5f241e1b3a69649ae2e04fbf5cc
https://doi.org/10.1007/bf02786077
https://doi.org/10.1007/bf02786077
Autor:
Chikako Takeichi, Tomoyuki Katsuzaki, Tokimune Shibata, Shinobu Hayakawa, Satoru Naruse, Tetsuo Hayakawa, Yasuyuki Nakae, Noriyuki Tatemichi
Publikováno v:
Journal of Clinical Laboratory Analysis. 6:143-147
Monoclonal antibodies were raised against human pancreatic stone protein (PSP) and used for one-step enzyme immunoassay (EIA). PSP-S2-5 was employed as the standard in the assay. The assay's measurable range was 25-1,500 ng/ml and within run coeffici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5baf24a6b576b9352accc14b6c597285
https://doi.org/10.1002/jcla.1860060308
https://doi.org/10.1002/jcla.1860060308
Autor:
Tomoyuki Katsuzaki, Chikako Takeichi, Tokimune Shibata, Shinobu Hayakawa, Hideo Harada, Tetsuo Hayakawa, Noriyuki Tatemichi, Koji Ochi
Publikováno v:
Journal of Clinical Laboratory Analysis. 6:375-378
In order to study the concentration of pancreatic stone protein (PSP) in human pancreatic juice, we investigated the influence of the insoluble form of PSP-S1 converted from PSP-S2-5 on PSP determination and the assay method for PSP-S1 precipitate af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::928b65e4dc9afbbafdd2468c8e321f48
https://doi.org/10.1002/jcla.1860060607
https://doi.org/10.1002/jcla.1860060607
Autor:
Noriyuki Tatemichi, Tomoko Yazawa, Tomoyuki Katsuzaki, Kenji Maeda, Toshimitsu Niwa, Kenji Kato
Publikováno v:
Clinica Chimica Acta. 186:391-396
Microalbuminuria, an increased excretion of urinary albumin undetectable by Albustix test strips, appears to predict the late development of diabetic nephropathy at a stage that albuminuria might be reduced by good metabolic control Once albuminuria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ff821ab3e183770e599c14c53a4cf81
https://doi.org/10.1016/0009-8981(90)90325-m
https://doi.org/10.1016/0009-8981(90)90325-m
Autor:
Fumitaka Hayase, Toshihiko Uematsu, Yoshifumi Takei, Tomoyuki Katsuzaki, Takashi Miyazaki, Toshimitsu Niwa, Noriyuki Tatemichi, Yayoi Ishizaki
Publikováno v:
FEBS letters. 407(3)
We produced a monoclonal antibody to imidazolones A and B, novel advanced glycation end products formed from the reaction of 3-deoxyglucosone (3-DG) with the guanidino group of arginine. Liquid chromatography/mass spectrometry demonstrated that the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5b5a9a3dd93f9a73edead0f769e006c
https://pubmed.ncbi.nlm.nih.gov/9175872
https://pubmed.ncbi.nlm.nih.gov/9175872
Autor:
Toshimitsu Niwa, Y Ishizaki, T Miyazaki, F Hayase, Noriyuki Tatemichi, Tomoyuki Katsuzaki, Y. Takei, S Miyazaki
Publikováno v:
The Journal of clinical investigation. 99(6)
To investigate the role of the Maillard reaction in the pathogenesis of diabetic complications, we produced several clones of monoclonal antibodies against advanced glycation end products (AGEs) by immunizing mice with AGE-modified keyhole limpet hem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f234cd0d9d21831d45d2095cdcb2e246
https://pubmed.ncbi.nlm.nih.gov/9077536
https://pubmed.ncbi.nlm.nih.gov/9077536
